Leadership changes, August 2026
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes
1,025
Appointments
572
Departures
82
Browse by role
August 2026
Get new CFO appointments the day the filing lands.
Filters
1,025 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Sunshine Biopharma Inc. | Andrew Keller | directordirector | Appointed | n/a | SEC 8-K |
| Aug 28, 2026 | Vyome Holdings, Inc | Jerry Leonard | Chief Financial OfficerCFO | Appointed | Sep 1, 2026 | SEC 8-K |
| Aug 28, 2026 | Vyome Holdings, Inc | Robert Dickey | Interim Chief Financial OfficerCFO | Departed | Aug 31, 2026 | SEC 8-K |
| Aug 28, 2026 | YUM BRANDS INC | Steve Bratspies | Board of DirectorsBoard of Directors | Appointed | n/a | SEC 8-K |
| Aug 27, 2026 | Affirm Holdings, Inc. | Michael Linford | PresidentPresident | Appointed | Aug 27, 2026 | SEC 8-K |
| Aug 27, 2026 | Alto Neuroscience, Inc. | Nicholas C. Smith | President and Chief Financial OfficerPresident | Appointed | Aug 26, 2026 | SEC 8-K |
| Aug 27, 2026 | Alto Neuroscience, Inc. | Amit Etkin, M.D., Ph.D. | PresidentPresident | Departed | Aug 26, 2026 | SEC 8-K |
| Aug 27, 2026 | APPLIED MATERIALS INC /DE | Akash Palkhiwala | directordirector | Appointed | Aug 27, 2026 | SEC 8-K |
| Aug 27, 2026 | Arthur J. Gallagher & Co. | Richard C. Cary | Controller and Chief Accounting OfficerController and Chief Accounting Officer | Departed | Sep 30, 2026 | SEC 8-K |
| Aug 27, 2026 | Arthur J. Gallagher & Co. | Kyle G. Koreyva | Controller and Chief Accounting OfficerController and Chief Accounting Officer | Appointed | Oct 1, 2026 | SEC 8-K |
| Aug 27, 2026 | Avantor, Inc. | Benoit Gourdier | Executive Vice President, Bioscience and Medtech ProductsExecutive Vice President, Bioscience and Medtech Products | Departed | Oct 14, 2026 | SEC 8-K |
| Aug 27, 2026 | BayFirst Financial Corp. | Anthony Leo | DirectorDirector | Departed | Aug 26, 2026 | SEC 8-K |
| Aug 27, 2026 | BUILD-A-BEAR WORKSHOP INC | David Henderson | Chief Growth OfficerChief Growth Officer | Departed | Aug 26, 2026 | SEC 8-K |
| Aug 27, 2026 | C3.ai, Inc. | John C. Dwyer | Class III directorClass III director | Appointed | Aug 25, 2026 | SEC 8-K |
| Aug 27, 2026 | CINTAS CORP | Melanie W. Barstad | directordirector | Departed | n/a | SEC 8-K |
| Aug 27, 2026 | Dine Brands Global, Inc. | Howard M. Berk | DirectorDirector | Departed | Sep 3, 2026 | SEC 8-K |
| Aug 27, 2026 | Dolby Laboratories, Inc. | Marc Whitten | President and Chief Executive Officer (principal executive officer)CEO | Appointed | Aug 27, 2026 | SEC 8-K |
| Aug 27, 2026 | Dolby Laboratories, Inc. | Kevin Yeaman | President, Chief Executive Officer and director of the CompanyCEO | Departed | Aug 27, 2026 | SEC 8-K |
| Aug 27, 2026 | Envoy Medical, Inc. | Robert Potashnick | Chief Accounting Officer and Vice President of FinanceChief Accounting Officer and Vice President of Finance | Appointed | Aug 24, 2026 | SEC 8-K |
| Aug 27, 2026 | GAP INC | Horacio “Haio” Barbeito | President and Chief Executive Officer of Old NavyCEO | Departed | Nov 2, 2026 | SEC 8-K |
- Sunshine Biopharma Inc.Appointed
Andrew Keller director
Filed Aug 28, 2026SEC 8-K
- Vyome Holdings, IncAppointed
Jerry Leonard CFO
Filed Aug 28, 2026Effective Sep 1, 2026SEC 8-K
- Vyome Holdings, IncDeparted
Robert Dickey CFO
Filed Aug 28, 2026Effective Aug 31, 2026SEC 8-K
- YUM BRANDS INCAppointed
Steve Bratspies Board of Directors
Filed Aug 28, 2026SEC 8-K
- Affirm Holdings, Inc.Appointed
Michael Linford President
Filed Aug 27, 2026Effective Aug 27, 2026SEC 8-K
- Alto Neuroscience, Inc.Appointed
Nicholas C. Smith President
Filed Aug 27, 2026Effective Aug 26, 2026SEC 8-K
- Alto Neuroscience, Inc.Departed
Amit Etkin, M.D., Ph.D. President
Filed Aug 27, 2026Effective Aug 26, 2026SEC 8-K
- APPLIED MATERIALS INC /DEAppointed
Akash Palkhiwala director
Filed Aug 27, 2026Effective Aug 27, 2026SEC 8-K
- Arthur J. Gallagher & Co.Departed
Richard C. Cary Controller and Chief Accounting Officer
Filed Aug 27, 2026Effective Sep 30, 2026SEC 8-K
- Arthur J. Gallagher & Co.Appointed
Kyle G. Koreyva Controller and Chief Accounting Officer
Filed Aug 27, 2026Effective Oct 1, 2026SEC 8-K
- Avantor, Inc.Departed
Benoit Gourdier Executive Vice President, Bioscience and Medtech Products
Filed Aug 27, 2026Effective Oct 14, 2026SEC 8-K
- BayFirst Financial Corp.Departed
Anthony Leo Director
Filed Aug 27, 2026Effective Aug 26, 2026SEC 8-K
- BUILD-A-BEAR WORKSHOP INCDeparted
David Henderson Chief Growth Officer
Filed Aug 27, 2026Effective Aug 26, 2026SEC 8-K
- C3.ai, Inc.Appointed
John C. Dwyer Class III director
Filed Aug 27, 2026Effective Aug 25, 2026SEC 8-K
- CINTAS CORPDeparted
Melanie W. Barstad director
Filed Aug 27, 2026SEC 8-K
- Dine Brands Global, Inc.Departed
Howard M. Berk Director
Filed Aug 27, 2026Effective Sep 3, 2026SEC 8-K
- Dolby Laboratories, Inc.Appointed
Marc Whitten CEO
Filed Aug 27, 2026Effective Aug 27, 2026SEC 8-K
- Dolby Laboratories, Inc.Departed
Kevin Yeaman CEO
Filed Aug 27, 2026Effective Aug 27, 2026SEC 8-K
- Envoy Medical, Inc.Appointed
Robert Potashnick Chief Accounting Officer and Vice President of Finance
Filed Aug 27, 2026Effective Aug 24, 2026SEC 8-K
- GAP INCDeparted
Horacio “Haio” Barbeito CEO
Filed Aug 27, 2026Effective Nov 2, 2026SEC 8-K